CLINICAL_TRIALS
trial_result
· 2021-11-01
Clinical Trial Update: Evaluation of Activity and Safety of Oral Selinexor in Participants With Severe COVID-19 Infection [Phase 2]
Summary
Phase 2 clinical trial evaluating oral selinexor in participants with severe COVID-19 completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karyopharm Therapeutics Inc | Conditions: Coronavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2021-11-01